Mexiletine-induced severe skin eruption, fever, eosinophilia, atypical lymphocytosis, and liver dysfunction

Pain

Volumn 73, Issue 1, 1997, Pages 97-99

  Higa, Kazuo ^a   Hirata, Kazuhiko ^a   Dan, Kenjiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Adverse drug reaction; Hypersensitivity syndrome; Mexiletine; Postherpetic neuralgia

Indexed keywords

DEXAMETHASONE; MEXILETINE;

ADULT; ARTICLE; CASE REPORT; EOSINOPHILIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER DYSFUNCTION; LYMPHOCYTOSIS; MALE; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RASH;

ANTI-ARRHYTHMIA AGENTS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; FEVER; HEPATITIS, TOXIC; HERPES ZOSTER; HUMANS; LIVER FUNCTION TESTS; LYMPHOCYTOSIS; MALE; MEXILETINE; MIDDLE AGED;

EID: 0030733256     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00066-3     Document Type: Article

References (14)

1. Avakian, R., Flowers, F.P., Araujo, O.E. and Ramos-Caro, F.A., Toxic epidermal necrolysis: a review, J. Am. Acad. Dermatol., 25 (1991) 69-79.
2. Backonja, M.-M., Local anesthetics as adjuvant analgesics, J. Pain Symptom Manage., 9 (1994) 491-499.
3. Campbell, N.P.S., Pantridge, J.F. and Adgey, A.A.J., Long-term oral antiarrhythmic therapy with mexiletine, Br. Heart J., 40 (1978) 796-801.
4. Dejgard, A., Petersen, P. and Kastrup, J., Mexiletine for treatment of chronic painful diabetic neuropathy, Lancet, 1 (1988) 9-11.
5. Galer, B.S., Harle, J. and Rowbotham, M.C., Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study, J. Pain Symptom Manage., 12 (1996) 161-167.
6. Heger, J.J., Nattel, S., Rinkenberger, R.L. and Zipes, D.P., Mexiletine therapy in 15 patients with drug-resistant ventricular tachycardia, Am. J. Cardiol., 45 (1980) 627-632.
7. Kikuchi, K., Tsunoda, T. and Tagami, H., Generalized drug eruption due to mexiletine hydrochloride: topical provocation on previously involved skin, Contact Dermatitis, 25 (1991) 70-72.
8. McQuay, H., Carroll, D., Jadad, A.R., Wiffen, P. and Moore, A., Anticonvulsant drugs for management of pain: a systematic review, Br. Med. J., 311 (1995) 1047-1052.
9. Monk, J.P. and Brogden, R.N., Mexiletine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias, Drugs, 40 (1990) 374-411.
10. Murphy, J.M., Mashman, J., Miller, J.D. and Bell, J.B., Suppression of carbamazepine-induced rash with prednisone, Neurology, 41 (1991) 144-145.
11. Pelekanos, J., Camfield, P., Camfield, C. and Gordon, K., Allergic rash due to antiepileptic drugs: clinical features and management, Epilepsia, 32 (1991) 554-559.
12. Roujeau, J.C. and Stern, R.S., Severe adverse cutaneous reactions to drugs, N. Engl. J. Med., 331 (1994) 1972.
13. Roujeau, J.-C., Kelly, J.P., Naldi, L., Rzany, B., Stern, R.S., Anderson, T., Auquier, A., Bastuji-Garin, S., Correia, O., Locati, F., Mockenhaupt, M., Paoletti, C., Shapiro, S., Shear, N., Schopf, E. and Kaufman, D.W., Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis, N. Engl. J. Med., 333 (1995) 1600-1607.
14. Tanelian, D.L. and Brose, W.G., Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine, Anesthesiology, 74 (1991) 949-951.